Thyrocare Tech.

₹621 -1.3 | 0.2%

WEBSITE BSE:539871 NSE : THYROCARE 10 May, 16:01

Market Cap ₹3288 Cr.

Stock P/E 50.1

P/B 6.6

Current Price ₹621

Book Value ₹ 94.6

Face Value 10

52W High ₹722

Dividend Yield 2.9%

52W Low ₹ 450

Edit Ratio

Thyrocare Tech. Research see more...

Overview Inc. Year: 2000Industry: Hospital & Healthcare Services

Thyrocare Technologies Ltd is an totally India-based healthcare service provider. The Company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia. The Company gives technologies, consisting of Chemiluminescence Immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Ion Selective Electrode (ISE), Fluorescence Flow Cytometry, Nephelometry, Photometry, Liquid Chromatography Mass Spectrometry (LC-MS), Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Cytogenetics. The Company offers cancer diagnosis and water testing through its manufacturers Nueclear and Whaters, respectively. The Company tests cover varied age businesses from services for prenatal screening, to screening for hormonal imbalance, dietary deficiencies and tracking way of life issues.

Thyrocare Tech. Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Thyrocare Tech. Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	176	117	131	128	135	128	136	135	148	135
Other Income	15	1	2	1	2	2	4	1	2	3
Total Income	191	119	133	129	137	130	140	136	150	137
Total Expenditure	87	81	93	92	103	100	111	100	110	103
Operating Profit	104	38	40	37	33	30	28	35	40	34
Interest	1	1	1	1	1	1	1	1	1	1
Depreciation	8	9	10	9	9	10	11	10	11	13
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	96	29	30	28	24	19	17	25	28	20
Provision for Tax	18	7	9	6	8	5	5	8	8	5
Profit After Tax	78	22	21	21	15	14	12	17	20	15
Adjustments	-0	-0	1	0	0	1	0	0	0	1
Profit After Adjustments	78	22	21	22	15	15	13	17	20	15
Adjusted Earnings Per Share	14.7	4.1	4	4.1	2.9	2.8	2.4	3.3	3.8	2.9

Thyrocare Tech. Profit & Loss

#(Fig in Cr.)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	183	241	304	356	403	434	495	589	527	554
Other Income	8	7	12	23	10	7	12	29	8	10
Total Income	191	248	317	379	413	441	507	618	535	563
Total Expenditure	110	147	189	212	249	261	323	353	404	424
Operating Profit	81	101	128	168	164	180	184	265	131	137
Interest	0	1	0	0	1	2	1	3	5	4
Depreciation	13	18	18	20	26	32	30	34	39	45
Exceptional Income / Expenses	0	0	-27	-2	0	-7	0	0	0	0
Profit Before Tax	68	82	82	145	138	140	152	228	89	90
Provision for Tax	24	30	39	52	53	52	39	52	24	26
Profit After Tax	44	52	43	93	85	88	113	176	64	64
Adjustments	1	0	0	0	0	0	-1	-0	2	1
Profit After Adjustments	45	52	43	93	85	89	112	176	66	65
Adjusted Earnings Per Share	8.9	9.6	8	17.4	16.1	16.8	21.1	33.3	12.4	12.4

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	-11%	7%	8%	0%
Operating Profit CAGR	-51%	-10%	-5%	0%
PAT CAGR	-64%	-10%	-7%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	35%	-16%	6%	NA%
ROE Average	12%	26%	24%	21%
ROCE Average	18%	35%	34%	31%

Thyrocare Tech. Balance Sheet

#(Fig in Cr.)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	276	366	408	443	435	367	427	527	534
Minority's Interest	36	0	0	0	0	0	0	0	1
Borrowings	0	0	7	0	3	3	0	0	0
Other Non-Current Liabilities	9	10	1	10	11	18	18	106	149
Total Current Liabilities	7	31	18	20	21	82	95	215	151
Total Liabilities	328	407	434	474	470	469	540	848	835
Fixed Assets	196	259	259	299	294	269	253	285	294
Other Non-Current Assets	22	14	26	33	39	48	47	142	194
Total Current Assets	111	134	150	142	117	121	200	421	347
Total Assets	328	407	434	474	470	469	540	848	835

Thyrocare Tech. Cash Flow

#(Fig in Cr.)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	11	5	10	10	10	5	9	13	14
Cash Flow from Operating Activities	34	68	90	107	100	168	115	113	129
Cash Flow from Investing Activities	-18	-18	-42	-43	-12	1	-49	-24	-39
Cash Flow from Financing Activities	-23	-45	-49	-64	-94	-165	-62	-89	-86
Net Cash Inflow / Outflow	-6	5	-0	-0	-5	4	4	0	4
Closing Cash & Cash Equivalent	5	10	10	10	5	9	13	14	18

Thyrocare Tech. Ratios

#	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	8.95	9.64	7.99	17.4	16.15	16.75	21.14	33.28	12.45
CEPS(Rs)	11.26	13.04	11.34	21.11	21.09	22.77	27.13	39.7	19.47
DPS(Rs)	3.76	10	10	10	20	5	25	15	18
Book NAV/Share(Rs)	54.53	67.57	75.02	81.99	81.69	68.68	80.26	98.89	100.09
Core EBITDA Margin(%)	39.72	39.03	37.91	40.62	38.28	39.97	34.62	40.03	23.27
EBIT Margin(%)	37.12	34.18	26.98	40.81	34.42	32.76	31	39.22	17.74
Pre Tax Margin(%)	36.96	33.95	26.83	40.69	34.27	32.33	30.83	38.67	16.82
PAT Margin (%)	24.07	21.5	14.08	26.18	21.13	20.36	22.88	29.91	12.22
Cash Profit Margin (%)	31.1	29.07	20.01	31.82	27.63	27.7	29	35.66	19.57
ROA(%)	13.41	14.09	10.19	20.55	18.05	18.84	22.43	25.38	7.65
ROE(%)	15.98	16.22	11.19	22.12	19.53	22.26	28.75	37.18	12.23
ROCE(%)	24.57	25.66	21.04	33.89	31.48	35.27	38.51	48.42	17.61
Receivable days	9.8	9.4	8.26	8.1	9.83	11.96	22.5	42.73	61.79
Inventory Days	14.7	13.7	15.12	16.16	15.91	16.26	16.23	14.84	18.09
Payable days	5.46	7.42	7.44	15.15	23.28	45.78	52.19	44.68	45.3
PER(x)	0	0	89.61	34.56	32.85	29.58	42.72	23.25	34.52
Price/Book(x)	0	0	9.54	7.33	6.49	7.22	11.25	7.82	4.29
Dividend Yield(%)	0	0	1.4	1.66	3.77	1.01	2.77	1.94	4.19
EV/Net Sales(x)	0.25	0.18	12.61	9.03	6.93	6.01	9.62	6.93	4.26
EV/Core EBITDA(x)	0.56	0.43	30.07	19.18	17.01	14.48	25.9	15.39	17.15
Net Sales Growth(%)	0	31.71	26.32	17.06	13.08	7.78	13.9	19.05	-10.56
EBIT Growth(%)	0	21.26	-0.26	77.06	-4.65	2.59	7.79	50.6	-59.55
PAT Growth(%)	0	17.63	-17.29	117.72	-8.73	3.83	28	55.67	-63.46
EPS Growth(%)	0	7.76	-17.17	117.82	-7.17	3.74	26.18	57.45	-62.6
Debt/Equity(x)	0	0	0.02	0	0.01	0.01	0	0	0
Current Ratio(x)	15.16	4.28	8.49	7	5.69	1.48	2.1	1.95	2.3
Quick Ratio(x)	14.15	3.94	7.66	6.16	4.82	1.23	1.86	1.84	2.11
Interest Cover(x)	226.39	149.46	177.4	330.52	227.33	76.9	176.25	71.94	19.34
Total Debt/Mcap(x)	0	0	0	0	0	0	0	0	0

Thyrocare Tech. Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	71.18	71.18	71.18	71.14	71.14	71.14	71.14	71.14	71.11	71.11
FII	12.02	12.68	12.82	10.42	10.13	10	3.44	3.46	3.35	2.9
DII	6.71	6.88	7.16	9.14	8.68	8.44	13.46	13.33	13.89	14.88
Public	10.09	9.26	8.85	9.3	10.04	10.42	11.96	12.07	11.65	11.1
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	3.77	3.77	3.77	3.77	3.77	3.77	3.77	3.77	3.77	3.77
FII	0.64	0.67	0.68	0.55	0.54	0.53	0.18	0.18	0.18	0.15
DII	0.35	0.36	0.38	0.48	0.46	0.45	0.71	0.71	0.74	0.79
Public	0.53	0.49	0.47	0.49	0.53	0.55	0.63	0.64	0.62	0.59
Others	0	0	0	0	0	0	0	0	0	0
Total	5.29	5.29	5.29	5.29	5.29	5.29	5.29	5.29	5.3	5.3

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 26%
Company is almost debt free.

Cons

Debtor days have increased from 44.68 to 45.3days.
Stock is trading at 6.6 times its book value.
The company has delivered a poor profit growth of -7% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Thyrocare Tech. News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

Current Price: 135/-

Lakeshore Hospital

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Thyrocare Tech.

Add Watchlist

Thyrocare Tech. Research see more...

Overview Inc. Year: 2000Industry: Hospital & Healthcare Services

Thyrocare Tech. Share Price

Alert Data

Quarterly Price

Peer Comparison

Thyrocare Tech. Quarterly Results

Thyrocare Tech. Profit & Loss

Growth Rates

Thyrocare Tech. Balance Sheet

Thyrocare Tech. Cash Flow

Thyrocare Tech. Ratios

Thyrocare Tech. Shareholding Pattern

Thyrocare Tech. News

Top Unlisted Companies & InstaBuy Companies

Lakeshore Hospital

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!